KR20240093898A - 피리디논 유도체의 경구용 제제 및 이의 장 섬유증 예방 및/또는 치료 용도 - Google Patents
피리디논 유도체의 경구용 제제 및 이의 장 섬유증 예방 및/또는 치료 용도 Download PDFInfo
- Publication number
- KR20240093898A KR20240093898A KR1020247017206A KR20247017206A KR20240093898A KR 20240093898 A KR20240093898 A KR 20240093898A KR 1020247017206 A KR1020247017206 A KR 1020247017206A KR 20247017206 A KR20247017206 A KR 20247017206A KR 20240093898 A KR20240093898 A KR 20240093898A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- methyl
- coated
- hpmcas
- eudragit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/501—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2021/079584 WO2023072368A1 (en) | 2021-10-25 | 2021-10-25 | Oral formulation of a pyridinone derivate and use thereof in prophylaxis and/or treatment of intestinal fibrosis |
| EPPCT/EP2021/079584 | 2021-10-25 | ||
| PCT/EP2022/079666 WO2023072878A1 (en) | 2021-10-25 | 2022-10-24 | Oral formulation of a pyridinone derivate and use thereof in prophylaxis and/or treatment of intestinal fibrosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20240093898A true KR20240093898A (ko) | 2024-06-24 |
Family
ID=78536154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020247017206A Pending KR20240093898A (ko) | 2021-10-25 | 2022-10-24 | 피리디논 유도체의 경구용 제제 및 이의 장 섬유증 예방 및/또는 치료 용도 |
Country Status (11)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL297020A (en) | 2020-04-24 | 2022-12-01 | Dr Falk Pharma Gmbh | A systemic preparation of a pyridonone derivative related to tg2 |
| HRP20231072T1 (hr) | 2020-04-24 | 2023-12-22 | Dr. Falk Pharma Gmbh | Sustavna formulacija derivata piridinona za celijakiju |
| WO2025153465A1 (en) * | 2024-01-15 | 2025-07-24 | UCB Biopharma SRL | Method for the treatment of fibrotic-related disorder associated to ibd |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102006052755A1 (de) * | 2006-11-08 | 2008-05-15 | N-Zyme Biotec Gmbh | Michaelsysteme als Transglutaminaseinhibitoren |
| EP2687511A1 (de) * | 2012-07-17 | 2014-01-22 | Zedira GmbH | Pyridinonderivate als Gewebetransglutaminaseinhibitoren |
-
2021
- 2021-10-25 WO PCT/EP2021/079584 patent/WO2023072368A1/en not_active Ceased
-
2022
- 2022-10-24 CN CN202280071095.9A patent/CN118234489A/zh active Pending
- 2022-10-24 JP JP2024524678A patent/JP2024536609A/ja active Pending
- 2022-10-24 US US18/704,228 patent/US20250041228A1/en active Pending
- 2022-10-24 CA CA3230682A patent/CA3230682A1/en active Pending
- 2022-10-24 EP EP22809386.0A patent/EP4312994A1/en active Pending
- 2022-10-24 MX MX2024005076A patent/MX2024005076A/es unknown
- 2022-10-24 KR KR1020247017206A patent/KR20240093898A/ko active Pending
- 2022-10-24 AU AU2022374695A patent/AU2022374695A1/en active Pending
- 2022-10-24 IL IL312176A patent/IL312176A/en unknown
- 2022-10-24 WO PCT/EP2022/079666 patent/WO2023072878A1/en not_active Ceased
-
2024
- 2024-04-10 ZA ZA2024/02786A patent/ZA202402786B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL312176A (en) | 2024-06-01 |
| JP2024536609A (ja) | 2024-10-04 |
| US20250041228A1 (en) | 2025-02-06 |
| WO2023072368A1 (en) | 2023-05-04 |
| WO2023072878A1 (en) | 2023-05-04 |
| CN118234489A (zh) | 2024-06-21 |
| EP4312994A1 (en) | 2024-02-07 |
| AU2022374695A1 (en) | 2024-03-21 |
| CA3230682A1 (en) | 2023-05-04 |
| ZA202402786B (en) | 2025-07-30 |
| MX2024005076A (es) | 2024-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102458117B (zh) | 含有非阿片样和阿片样止痛药的组合的口腔崩解片组合物 | |
| US20250041228A1 (en) | Oral formulation of a pyridinone derivate and use thereof in prophylaxis and/or treatment of intestinal fibrosis | |
| PL195587B1 (pl) | Powleczona powłoczką dojelitową kompozycja farmaceutyczna w postaci tabletki | |
| HUP0500832A2 (en) | Pharmaceutical pellets comprising tamsulosin and process for making the same | |
| CN101287443B (zh) | pH控制的脉冲释放系统、其制备方法和用途 | |
| TW201742621A (zh) | 包含經黏膜黏附性材料包覆之個別核心單元之核心及核心腸衣之多單元劑型 | |
| JP7625601B2 (ja) | 病気の治療又は予防において使用するための剤形 | |
| EP4340847A1 (en) | Composition of mesalazine enteric tablet formulation | |
| CN104739819A (zh) | 新型制剂 | |
| JP2009504729A (ja) | α1受容体拮抗薬の徐放性ペレット製剤及びその製造方法 | |
| EP2533766A2 (en) | Pharmaceutical mini-tablets for sustained release of flecainide acetate | |
| US20050147663A1 (en) | Method of treatment for improved bioavailability | |
| AU2008365126A1 (en) | Tamsulosin pellets for fixed dose combination | |
| US20090136550A1 (en) | Modified release formulations of diltiazem | |
| AU2005261958A1 (en) | Granules for controlled release of Tamsulosin | |
| CN108697648A (zh) | 含埃索美拉唑的制剂 | |
| RS63628B1 (sr) | Pelete sa višeslojnom strukturom za odloženo oslobađanje aktivnog sredstva u distalnom kolonu | |
| CZ118899A3 (cs) | Kompozice s pozvolným uvolňováním léčiva, způsob přípravy této kompozice, způsob zlepšení profilu uvolňování léčiva a použití této kompozice | |
| EA051945B1 (ru) | Пероральный препарат производного пиридинона и его применение для профилактики и/или лечения фиброза кишечника | |
| EP3380084B1 (en) | Omeprazole formulations | |
| CN101247792B (zh) | 包含pH依赖性药物、pH调节剂和阻滞剂的药物组合物 | |
| EA043403B1 (ru) | Пеллета с многослойной структурой для замедленного высвобождения действующего вещества в дистальный отдел толстой кишки | |
| TR2023014802T2 (tr) | Mesalazi̇n enteri̇k tablet formülasyon bi̇leşi̇mi̇ | |
| JP2017203031A (ja) | pH制御パルス送達システム、その調製法及び使用法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E13 | Pre-grant limitation requested |
Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |